Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as antihypertensive, antidiabetics, antibiotics diuretics, and antiretrovirals.
Medico Remedies Limited (MEDICO) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The MEDICO share price is ₹18.88 (+4.89% today), with a market capitalisation of ₹2B and a price-to-earnings (P/E) ratio of 11.3. MarketRipple tracks the MEDICO investment thesis, the ripple-chain impact of market events on Medico Remedies Limited, and the Healthcare sector outlook.
Open
₹19.20
High
₹20.00
Low
₹18.40
Prev. Close
₹18.00
52W High
₹56.88
52W Low
₹17.81
Day range
₹18.40–₹20.00
52-week range
₹17.81–₹56.88
Volume
603K
P/E
11.3
ROE
17.4%
D/E
0.26
Margin
5.8%
Medico Remedies Limited (NSE: MEDICO) is currently trading at ₹18.88 (+4.89%).
Medico Remedies Limited's market capitalization is ₹2B.
Medico Remedies Limited's price-to-earnings (P/E) ratio is 11.3.
Medico Remedies Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).